Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Gervasini

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Pharmacogenetics|July 31, 1998
Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamineJ A Agúndez, L Gallardo, C Martínez, et al.
Pharmacogenetics|April 1, 1997
Tryptamine: a possible endogenous substrate for CYP2D6C Martínez, J A Agúndez, G Gervasini, et al.
Pharmacogenetics|February 24, 2001
Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenalineG Gervasini, C Martínez, J A Agúndez, et al.
Current Molecular Medicine|June 9, 2018
Association of COMT Val158Met Polymorphism with Psychopathological Symptoms in Patients with Eating DisordersG Gervasini, L M Gonzalez, S Mota-Zamorano, et al.
Drug Metabolism Letters|April 10, 2009
Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepamM Olivera, C Martínez, G Gervasini, et al.
Physical Review Letters|October 13, 2007
Observation of the effects of dust particles on plasma fluctuation spectraS Ratynskaia, M De Angeli, U de Angelis, et al.
European Journal of Clinical Pharmacology|July 6, 2000
Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursorsC Martínez, G Gervasini, J A Agúndez, et al.
The Pharmacogenomics Journal|September 24, 2014
Impact of NEGR1 genetic variability on psychological traits of patients with eating disordersC Gamero-Villarroel, L María González, I Gordillo, et al.
Allergy|July 9, 2010
Variability of the L-Histidine decarboxylase gene in allergic rhinitisG Gervasini, J A G Agúndez, J García-Menaya, et al.
The Review of Scientific Instruments|March 3, 2012
A neutron diagnostic for high current deuterium beamsM Rebai, M Cavenago, G Croci, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Pharmacogenetics|July 31, 1998
Modulation of CYP1A2 enzyme activity by indoleamines: inhibition by serotonin and tryptamineJ A Agúndez, L Gallardo, C Martínez, et al.
Pharmacogenetics|April 1, 1997
Tryptamine: a possible endogenous substrate for CYP2D6C Martínez, J A Agúndez, G Gervasini, et al.
Pharmacogenetics|February 24, 2001
Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenalineG Gervasini, C Martínez, J A Agúndez, et al.
Current Molecular Medicine|June 9, 2018
Association of COMT Val158Met Polymorphism with Psychopathological Symptoms in Patients with Eating DisordersG Gervasini, L M Gonzalez, S Mota-Zamorano, et al.
Drug Metabolism Letters|April 10, 2009
Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepamM Olivera, C Martínez, G Gervasini, et al.
Physical Review Letters|October 13, 2007
Observation of the effects of dust particles on plasma fluctuation spectraS Ratynskaia, M De Angeli, U de Angelis, et al.
European Journal of Clinical Pharmacology|July 6, 2000
Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursorsC Martínez, G Gervasini, J A Agúndez, et al.
The Pharmacogenomics Journal|September 24, 2014
Impact of NEGR1 genetic variability on psychological traits of patients with eating disordersC Gamero-Villarroel, L María González, I Gordillo, et al.
Allergy|July 9, 2010
Variability of the L-Histidine decarboxylase gene in allergic rhinitisG Gervasini, J A G Agúndez, J García-Menaya, et al.
The Review of Scientific Instruments|March 3, 2012
A neutron diagnostic for high current deuterium beamsM Rebai, M Cavenago, G Croci, et al.
Pageof 1